IOL Chemicals and Pharmaceuticals Ltd

NSE: IOLCP · BSE: 524164 · Pharmaceuticals & Biotechnology · 31 announcements

IOL Chemicals and Pharmaceuticals Ltd news stories on ALFA NewsRead the news →

Share price: ₹219.35
Market cap: ₹6,439 Cr
Revenue (annual): ₹2,319 Cr
Net profit (annual): ₹137.6 Cr
P/E (TTM): 38.3×Sector 47.4×
Promoter holding: 62.28%+4.80% QoQ
FII holding: 4.87%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 3 Regulatory Approval 2 Other Announcement 2 Capacity Expansion 2 Annual General Meeting 2 Results Update 1 Financial Results 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

23 Sep 2026 16:07 IST BSE

Regulatory ApprovalAlfa Alert

IOL Chemicals and Pharmaceuticals Regulatory Approval

IOL Chemicals and Pharmaceuticals Limited received EU-REACH registration for its product 'Triacetin', enabling the company to export this product to countries in the European Union.

Read the story on ALFA News Read the filing ↗

14 Jul 2026 16:46 IST NSE

Regulatory Approval

IOL Chemicals and Pharmaceuticals Regulatory Approval

IOL Chemicals received NMPA China approval for its Clopidogrel Bisulfate API. This strengthens its regulatory portfolio and expands access to the Chinese pharmaceutical market.

Read the filing ↗